PlainRecalls
FDA Drug Critical Class I Terminated

Tetracycline HCL Capsules, USP, 250 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc. East Brunswick NJ 08816. NDC 23155-017-01

Reported: April 15, 2020 Initiated: March 23, 2020 #D-1255-2020

Product Description

Tetracycline HCL Capsules, USP, 250 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc. East Brunswick NJ 08816. NDC 23155-017-01

Reason for Recall

Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.

Details

Units Affected
4,444 bottles
Distribution
Distributed Nationwide in the US
Location
East Brunswick, NJ

Frequently Asked Questions

What product was recalled?
Tetracycline HCL Capsules, USP, 250 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc. East Brunswick NJ 08816. NDC 23155-017-01. Recalled by Avet Pharmaceuticals, Inc.. Units affected: 4,444 bottles.
Why was this product recalled?
Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 15, 2020. Severity: Critical. Recall number: D-1255-2020.